Reaction
Anticipatory Anxiety reporting signals
As of the last recalculation, Anticipatory Anxiety appears in 267 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is DESOXIMETASONE (PRR 632.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Desoximetasone | 98 | 632.9 | 636.2 |
| Cetirizine Hydrochloride Allergy | 98 | 398.0 | 399.3 |
| Cetirizine Hydrochloride Tablets | 98 | 397.9 | 399.2 |
| Cetirizine | 99 | 157.5 | 157.7 |
| Hydroxychloroquine Sulfate | 102 | 140.6 | 140.8 |
| Hydroxychloroquine | 86 | 132.0 | 132.1 |
| Tocilizumab | 110 | 127.1 | 127.2 |
| Abatacept | 109 | 103.0 | 103.1 |
| Moxifloxacin Hydrochloride | 20 | 83.0 | 83.1 |
| Tofacitinib Citrate | 13 | 81.2 | 81.3 |
| Tofacitinib | 108 | 76.0 | 76.0 |
| Exemestane | 19 | 74.4 | 74.4 |
| Golimumab | 60 | 70.1 | 70.1 |
| Leflunomide | 69 | 69.0 | 69.0 |